Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
ZOTA.NS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q3.22
N/A
0.36
vs NA
Q4.22
N/A
-1.28
vs NA
Q1.23
N/A
-1.05
vs -0.40
Q2.23
N/A
-1.13
vs -0.33
Q3.23
N/A
-0.64
vs 0.36
Q4.23
N/A
-1.14
vs -1.28
Q1.24
N/A
-2.68
vs -1.05
Q2.24
N/A
-4.80
vs -1.13
Q3.24
N/A
-4.57
vs -0.64
Q4.24
N/A
-6.80
vs -1.14
Sales Growth
YoY
Current
Estimates
Q3.22
+10%
389.5M vs 353.9M
Q4.22
+13%
349.7M vs 310.2M
Q1.23
+18%
368.5M vs 313.4M
Q2.23
+32%
386.5M vs 291.9M
Q3.23
+16%
452.7M vs 389.5M
Q4.23
+34%
469.3M vs 349.7M
Q1.24
+35%
496.4M vs 368.5M
Q2.24
+46%
563M vs 386.5M
Q3.24
+49%
672.8M vs 452.7M
Q4.24
+54%
721.2M vs 469.3M
Return on Equity
QoQ
Q1.23
-3%
-0.03
vs -0.04
Q2.23
-4%
-0.04
vs -0.03
Q3.23
-2%
-0.02
vs -0.04
Q4.23
-3%
-0.03
vs -0.02
Q1.24
-8%
-0.08
vs -0.03
Q2.24
-14%
-0.14
vs -0.08
Q3.24
-8%
-0.08
vs -0.14
Q4.24
NA
NA
vs -0.08
Institutionnal Ownership
Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India. It offers generic drugs, over-the-counter products, ayurvedic products, and nutraceutical products. The company provides various medicines for chronic illnesses, including heart disease, diabetes, thyroid, and others. As of March 31, 2021, it operated 591 retail stores under the DAVAINDIA name in 24 states of India. The company was founded in 1995 and is headquartered in Surat, India.
NSE
Unprofitable
Unprofitable
11.60Â ( 1.23%)
Relative Strenght
Volume Buzz
-77%
Earning Acce
No
Dist 52w H.
12%Relative Strength
ZOTA.NS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Quote Panel
Key Metrics
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How ZOTA.NS compares to sector?